Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

Recordati today announces an agreement with Sanofi to acquire the global rights to Enjaymo® (sutimlimab), a biologic ...

Under the deal announced Friday, the Italian pharma will make an upfront payment of $825 million to Sanofi for global rights ...

US FDA accepts and grants priority review status to AstraZeneca’s sNDA for Calquence to treat patients with untreated MCL: Cambridge, UK Friday, October 4, 2024, 09:00 Hrs [IST] ...

Discovery could lead to development of new drugs to treat inflammation, coronary artery disease, cancer, more Steven Mansoor, ...

The trial is already enrolling solid tumour patients in the US, with the FDA greenlighting the trial last year.

A phase I trial found that the next-generation yellow fever vaccine (vYF) triggers immune responses and offers safety similar ...

What makes this autoimmune reaction so deadly is that the TLRs also activate the body's second-line defense, the more powerful adaptive immune response, mobilizing T and B cells, macrophages, and ...